Company / Operating Cash Flow per Share
Tvardi Therapeutics, Inc. Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$17.34
FY2024
5-year range
-$17.34 / -$0.10
FY2020-FY2024
Trend
-1452.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -1453% YoY in FY2024, a notable deviation from the 9-year average annual change of -374%.
Based on SEC 10-K filings.
-17.34 in FY2024.
Declined from $-0.10 to $-17.34 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 1452.6% year-over-year.
- Peak operating cash flow per share was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$17.34 | -1452.6% |
| FY2023 | -$1.12 | -988.6% |
| FY2022 | -$0.10 | +95.3% |
| FY2021 | -$2.19 | -358.8% |
| FY2020 | -$0.48 | +65.6% |
| FY2019 | -$1.39 | +4.4% |
| FY2018 | -$1.45 | -84.4% |
| FY2017 | -$0.79 | -21.6% |
| FY2016 | -$0.65 | -621.7% |
| FY2015 | $0.12 | +108.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026